Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.39
+0.07 (0.84%)
Nov 22, 2024, 4:00 PM EST - Market closed
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.60 billion as of November 22, 2024. Its market cap has increased by 101.58% in one year.
Market Cap
2.60B
Enterprise Value
5.23B
1-Year Change
101.58%
Ranking
Category
Stock Price
$8.39
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.60B, a decrease of -54.87%. That is a compound annual growth rate of -11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.62B | 40.54% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LivaNova | 2.72B |
| Concentra Group Holdings Parent | 2.71B |
| ACADIA Pharmaceuticals | 2.71B |
| PACS Group | 2.68B |
| Scholar Rock Holding | 2.61B |
| TransMedics Group | 2.59B |
| Zai Lab | 2.58B |
| Janux Therapeutics | 2.57B |